Terpenoid ID | TKC020117 | |
Cell line | 0 | |
Protein target | 40 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 114 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC020117 | FM3A | FM3A clone 28; FM3A cl28 | 1100.0 | nM | IC50 | C21678 | |
TKC020117 | KB | KB (HeLa derivative); HeLa-KB; Strain KB | 1.0 | ug ml-1 | ID50 | C27677 | |
TKC020117 | Ehrlich | Ehrlich-Lettre; Ehrlich Lettre; E-La; EAT; EAT strain E; Ehrlich ascites; Ehrlich | 1.0 | ug.mL-1 | IC50 | C21678 | |
TKC020117 | HT-22 | HT-22 | 4800.0 | nM | EC50 | ||
TKC020117 | SN12C | SN-12C | 11194.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020117 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 8091.0 | nM | GI50 | C3512 | |
TKC020117 | ACHN | 3334.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC020117 | UO-31 | UO.31; UO31; U031 | 10520.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020117 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 15922.0 | nM | GI50 | C2926 | |
TKC020117 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 24547.0 | nM | GI50 | C3510 | |
TKC020117 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 5309.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC020117 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 12589.0 | nM | GI50 | C3224 | |
TKC020117 | A498 | A498 | 44055.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020117 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 4046.0 | nM | GI50 | C105555 | |
TKC020117 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 3177.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC020117 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 10864.0 | nM | GI50 | C3512 | |
TKC020117 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 9120.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC020117 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 4446.0 | nM | GI50 | C105555 | |
TKC020117 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 15704.0 | nM | GI50 | C105555 | |
TKC020117 | DMS-273 | DMS-273; DMS273; Darmouth Medical School 273 | 3828.0 | nM | GI50 | C4917 | Orphanet_70573 |
TKC020117 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 10864.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC020117 | TK-10 | TK.10; TK 10; TK10 | 58076.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC020117 | SR | SR-786; SR786 | 2838.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC020117 | SW-620 | SW-620; SW 620; SW.620 | 4400.0 | nM | IC50 | C4349 | |
TKC020117 | M19-MEL | M-19; M19 | 13305.0 | nM | GI50 | C3802 | |
TKC020117 | KM12 | KM-12; KM.12 | 12388.0 | nM | GI50 | C4910 | |
TKC020117 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 3819.0 | nM | GI50 | C3512 | |
TKC020117 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 8492.0 | nM | GI50 | C3802 | |
TKC020117 | XF498 | XF-498; XF498 | 4236.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020117 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 11940.0 | nM | GI50 | C2923 | |
TKC020117 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 7925.0 | nM | GI50 | C3242 | Orphanet_29073 |
TKC020117 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 5058.0 | nM | GI50 | C3802 | |
TKC020117 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 7228.0 | nM | GI50 | C105555 | |
TKC020117 | KM-20L2 | KM-20L2; KM 20L2; KM 2012 | 4266.0 | nM | GI50 | C4349 | |
TKC020117 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 12134.0 | nM | GI50 | C3224 | |
TKC020117 | A549 | 9354.0 | nM | GI50 | C3512 | ||
TKC020117 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 9226.0 | nM | GI50 | C4349 | |
TKC020117 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 24378.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020117 | HCT-15 | HCT-15; HCT.15; HCT15 | 5140.0 | nM | GI50 | C4349 | |
TKC020117 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 4500.0 | nM | IC50 | C4910 | |
TKC020117 | SF-268 | SF-268; SF.268; SF 268 | 6368.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC020117 | EKVX | 17258.0 | nM | GI50 | C3512 | ||
TKC020117 | LXFL 529 | LXFL-529L; LXFL529L; LXF 529 L; LXFL-529; LXFL 529; LXFL529; LXF 529 | 6855.0 | nM | GI50 | C2926 | |
TKC020117 | DMS-114 | DMS-114; DMS114; Darmouth Medical School 114 | 3715.0 | nM | GI50 | C4917 | Orphanet_70573 |
TKC020117 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 49431.0 | nM | GI50 | C7978 | |
TKC020117 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 6982.0 | nM | GI50 | C4450 | |
TKC020117 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 16069.0 | nM | GI50 | C3224 | |
TKC020117 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 5794.0 | nM | GI50 | C3224 | |
TKC020117 | SF-295 | SF-295; SF.295; SF 295 | 6516.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020117 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 13521.0 | nM | GI50 | C7979 | Orphanet_454723 |
TKC020117 | RXF 631 | RXF-631L; RXF631L; RXF 631; RXF-631; RXF631 | 30549.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020117 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 5224.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020117 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 4102.0 | nM | GI50 | C3224 | |
TKC020117 | SNB-78 | SNB78; Surgical Neurology Branch-78 | 48306.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020117 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 2793.0 | nM | GI50 | C7953 | Orphanet_99861 |
TKC020117 | DLD-1 | DLD 1; DLD1; CoCL3 | 5309.0 | nM | GI50 | C4349 | |
TKC020117 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 11015.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC020117 | HT-29 | HT 29; HT29 | 4266.0 | nM | GI50 | C4349 | |
TKC020117 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 18880.0 | nM | GI50 | C3510 | |
TKC020117 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 25410.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020117 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 4236.0 | nM | GI50 | C4349 | |
TKC020117 | HOP-18 | HOP 18; Hop 18; HOP18; Hop18; Hopkins-18 | 15311.0 | nM | GI50 | C4450 | |
TKC020117 | MDCK | MDCK (NBL-2); NBL-2; Madin-Darby Canine Kidney; Madin Darby Canine Kidney | 10.0 | ug.mL-1 | MIC | ||
TKC020117 | Colon 26 | 26-L5; Colon26 clone 5 | 10.0 | ug.mL-1 | MIC | C120044 | |
TKC020117 | BXPC-3 | BxPc-3; BXPC-3; Bx-PC3; BXPC3; BxPC3; BxPc3; Biopsy xenograft of Pancreatic Carcinoma line-3 | 19000.0 | nM | GI50 | C9120 | |
TKC020117 | HuT78 | Hut 78; HUT 78; HuT-78; HUT-78; HuT78; Hut78; HUT78; NCI-H78 | 4990.0 | nM | GI50 | C3366 | Orphanet_3162 |
TKC020117 | Jurkat | JURKAT; JM; JM-Jurkat; Jurkat-FHCRC; Jurkat FHCRC; FHCRC-11; FHCRC subclone 11; FCCH1024 | 1100.0 | nM | GI50 | C7953 | Orphanet_99861 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC020117 | P00352 | Retinal dehydrogenase 1 | ALDH1A1 | 14125 | nM | Potency |
TKC020117 | P10636 | Microtubule-associated protein tau | MAPT | 15849 | nM | Potency |
TKC020117 | P11473 | Vitamin D3 receptor | VDR | 56234 | nM | Potency |
TKC020117 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 8913 | nM | Potency |
TKC020117 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 8913 | nM | Potency |
TKC020117 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 6513 | nM | Potency |
TKC020117 | P08684 | Cytochrome P450 3A4 | CYP3A4 | 631 | nM | Potency |
TKC020117 | P43220 | Glucagon-like peptide 1 receptor | GLP1R | 2239 | nM | Potency |
TKC020117 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 18356 | nM | Potency |
TKC020117 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 14125 | nM | Potency |
TKC020117 | Q962Y6 | Thioredoxin glutathione reductase | TGR | 89125 | nM | Potency |
TKC020117 | P29477 | Nitric oxide synthase, inducible | Nos2 | 18 | % | Inhibition |
TKC020117 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 19953 | nM | Potency |
TKC020117 | P03956 | Interstitial collagenase | MMP1 | 95 | % | Inhibition |
TKC020117 | P0DTD1 | Replicase polyprotein 1ab | rep | 12 | % | Inhibition |
TKC020117 | P14780 | Matrix metalloproteinase-9 | MMP9 | 99 | % | Inhibition |
TKC020117 | P83916 | Chromobox protein homolog 1 | CBX1 | 100000 | nM | Potency |
TKC020117 | P00811 | Beta-lactamase | ampC | 3548 | nM | Potency |
TKC020117 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 11220 | nM | Potency |
TKC020117 | Q96QE3 | ATPase family AAA domain-containing protein 5 | ATAD5 | 16354 | nM | Potency |
TKC020117 | B2RXH2 | Lysine-specific demethylase 4E | KDM4E | 7943 | nM | Potency |
TKC020117 | O15296 | Polyunsaturated fatty acid lipoxygenase ALOX15B | ALOX15B | 12589 | nM | Potency |
TKC020117 | O97447 | Putative fructose-1,6-bisphosphate aldolase | fba | 14092 | nM | Potency |
TKC020117 | P02791 | Ferritin light chain | FTL | 35481 | nM | Potency |
TKC020117 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | HPGD | 39811 | nM | Potency |
TKC020117 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 56234 | nM | Potency |
TKC020117 | Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | BAZ2B | 56234 | nM | Potency |
TKC020117 | P16050 | Polyunsaturated fatty acid lipoxygenase ALOX15 | ALOX15 | 39811 | nM | Potency |
TKC020117 | P18054 | Polyunsaturated fatty acid lipoxygenase ALOX12 | ALOX12 | 2512 | nM | Potency |
TKC020117 | Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | APOBEC3F | 31623 | nM | Potency |
TKC020117 | P51450 | Nuclear receptor ROR-gamma | Rorc | 1995 | nM | Potency |
TKC020117 | P15917 | Lethal factor | lef | 66 | % | Inhibition |
TKC020117 | P08253 | 72 kDa type IV collagenase | MMP2 | 90 | % | Inhibition |
TKC020117 | P08254 | Stromelysin-1 | MMP3 | 98 | % | Inhibition |
TKC020117 | P22894 | Neutrophil collagenase | MMP8 | 100 | % | Inhibition |
TKC020117 | P42858 | Huntingtin | HTT | 8913 | nM | Potency |
TKC020117 | P04637 | Cellular tumor antigen p53 | TP53 | 12589 | nM | Potency |
TKC020117 | Q194T2 | Non-structural protein 1 | NS1 | 17783 | nM | Potency |
TKC020117 | Q9UBN7 | Histone deacetylase 6 | HDAC6 | >2500 | nM | Ki |
TKC020117 | O42713 | Polyphenol oxidase 2 | PPO2 | 60 | nM | Ki |
TKC020117 | P14679 | Tyrosinase | TYR | 8980 | nM | IC50 |
TKC020117 | P00730 | Carboxypeptidase A1 | CPA1 | 2760 | nM | IC50 |
TKC020117 | P00800 | Thermolysin | npr | 61000 | nM | IC50 |
TKC020117 | P09917 | Polyunsaturated fatty acid 5-lipoxygenase | ALOX5 | -67 | % | Inhibition |
TKC020117 | P56524 | Histone deacetylase 4 | HDAC4 | >20000 | nM | Ki |
TKC020117 | P56524 | Histone deacetylase 4 | HDAC4 | 3.32 | nM | Ki |
TKC020117 | Q00987 | E3 ubiquitin-protein ligase Mdm2 | MDM2 | 3580 | nM | IC50 |
TKC020117 | Q92769 | Histone deacetylase 2 | HDAC2 | 15 | nM | Ki |
TKC020117 | Q9BY41 | Histone deacetylase 8 | HDAC8 | 178 | nM | Ki |
TKC020117 | Q9BY41 | Histone deacetylase 8 | HDAC8 | 105 | nM | Ki |
TKC020117 | Q9UQL6 | Histone deacetylase 5 | HDAC5 | >2500 | nM | Ki |
TKC020117 | Q9X721 | Collagenase ColG | colG | 24000 | nM | IC50 |
TKC020117 | O15151 | Protein Mdm4 | MDM4 | 3580 | nM | IC50 |
TKC020117 | Q99728 | BRCA1-associated RING domain protein 1 | BARD1 | 3890 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
P08684 | CP3A4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 | CP3A4_HUMAN | Atopic eczema [ICD-11: EA80] |
P08684 | CP3A4_HUMAN | Anxiety disorder [ICD-11: 6B00-6B0Z] |
P43220 | GLP1R_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 | GLP1R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P43220 | GLP1R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 | GLP1R_HUMAN | Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 | GLP1R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P43220 | GLP1R_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
P43220 | GLP1R_HUMAN | Dyspepsia [ICD-11: MD92] |
P43220 | GLP1R_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
P43220 | GLP1R_HUMAN | Intracranial injury [ICD-11: NA07] |
P43220 | GLP1R_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
Q13148 | TADBP_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 | TADBP_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P03956 | MMP1_HUMAN | Brain cancer [ICD-11: 2A00] |
P03956 | MMP1_HUMAN | Lung cancer [ICD-11: 2C25] |
P03956 | MMP1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P03956 | MMP1_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P03956 | MMP1_HUMAN | Kaposi sarcoma [ICD-11: 2B57] |
P03956 | MMP1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P03956 | MMP1_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P03956 | MMP1_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P03956 | MMP1_HUMAN | Hepatitis virus infection [ICD-11: 1E50-1E51] |
P03956 | MMP1_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P03956 | MMP1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P14780 | MMP9_HUMAN | Crohn disease [ICD-11: DD70] |
P14780 | MMP9_HUMAN | Ischaemic/haemorrhagic stroke [ICD-11: 8B20] |
P14780 | MMP9_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P14780 | MMP9_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P14780 | MMP9_HUMAN | Stomach cancer [ICD-11: 2B72] |
P14780 | MMP9_HUMAN | Ulcerative colitis [ICD-11: DD71] |
P14780 | MMP9_HUMAN | Brain cancer [ICD-11: 2A00] |
P14780 | MMP9_HUMAN | Lung cancer [ICD-11: 2C25] |
P14780 | MMP9_HUMAN | Renal cell carcinoma [ICD-11: 2C90] |
P14780 | MMP9_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P14780 | MMP9_HUMAN | Hepatitis virus infection [ICD-11: 1E50-1E51] |
P14780 | MMP9_HUMAN | Colorectal cancer [ICD-11: 2B91] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P15917 | LEF_BACAN | Sepsis [ICD-11: 1G40-1G41] |
P15917 | LEF_BACAN | Corneal disease [ICD-11: 9A76-9A78] |
P08253 | MMP2_HUMAN | Brain cancer [ICD-11: 2A00] |
P08253 | MMP2_HUMAN | Lung cancer [ICD-11: 2C25] |
P08253 | MMP2_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
P08253 | MMP2_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P08253 | MMP2_HUMAN | Acne vulgaris [ICD-11: ED80] |
P08253 | MMP2_HUMAN | Renal cell carcinoma [ICD-11: 2C90] |
P08253 | MMP2_HUMAN | Kaposi sarcoma [ICD-11: 2B57] |
P08253 | MMP2_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
P08253 | MMP2_HUMAN | Ovarian cancer [ICD-11: 2C73] |
P08253 | MMP2_HUMAN | Prostate cancer [ICD-11: 2C82] |
P08253 | MMP2_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P08253 | MMP2_HUMAN | Hepatitis virus infection [ICD-11: 1E50-1E51] |
P08253 | MMP2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08253 | MMP2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P08254 | MMP3_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P08254 | MMP3_HUMAN | Hepatitis virus infection [ICD-11: 1E50-1E51] |
P08254 | MMP3_HUMAN | Myocardial infarction [ICD-11: BA41-BA43] |
P08254 | MMP3_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
P08254 | MMP3_HUMAN | Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P08254 | MMP3_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P08254 | MMP3_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P22894 | MMP8_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P22894 | MMP8_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P22894 | MMP8_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P42858 | HD_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P04637 | P53_HUMAN | Arterial occlusive disease [ICD-11: BD40] |
P04637 | P53_HUMAN | Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
P04637 | P53_HUMAN | Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
P04637 | P53_HUMAN | Transplant rejection [ICD-11: NE84] |
P04637 | P53_HUMAN | Ovarian dysfunction [ICD-11: 5A80] |
P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 | P53_HUMAN | Bladder cancer [ICD-11: 2C94] |
P04637 | P53_HUMAN | Brain cancer [ICD-11: 2A00] |
P04637 | P53_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P04637 | P53_HUMAN | Esophageal cancer [ICD-11: 2B70] |
P04637 | P53_HUMAN | Head and neck cancer [ICD-11: 2D42] |
P04637 | P53_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
P04637 | P53_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P04637 | P53_HUMAN | Ovarian cancer [ICD-11: 2C73] |
P04637 | P53_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 | P53_HUMAN | Stomach cancer [ICD-11: 2B72] |
P04637 | P53_HUMAN | Cervical cancer [ICD-11: 2C77] |
P04637 | P53_HUMAN | Endometrial cancer [ICD-11: 2C76] |
P04637 | P53_HUMAN | Fallopian tube cancer [ICD-11: 2C74] |
P04637 | P53_HUMAN | Liposarcoma [ICD-11: 2B59] |
P04637 | P53_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P04637 | P53_HUMAN | Peritoneal cancer [ICD-11: 2C51] |
P04637 | P53_HUMAN | Toxicity [ICD-11: N.A.] |
P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 | P53_HUMAN | Kidney failure [ICD-11: GB60-GB6Z] |
P04637 | P53_HUMAN | Hearing disorder [ICD-11: AB50-AB57] |
Q9UBN7 | HDAC6_HUMAN | Multiple myeloma [ICD-11: 2A83] |
Q9UBN7 | HDAC6_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P14679 | TYRO_HUMAN | Acquired hypermelanosis [ICD-11: ED60] |
P14679 | TYRO_HUMAN | Acquired hypomelanotic disorder [ICD-11: ED63] |
P14679 | TYRO_HUMAN | Melanoma [ICD-11: 2C30] |
P14679 | TYRO_HUMAN | Acquired melanotic macule/lentigine [ICD-11: ED61] |
P14679 | TYRO_HUMAN | Mineral absorption/transport disorder [ICD-11: 5C64] |
P14679 | TYRO_HUMAN | Skin pigmentation genetic disorder [ICD-11: EC23] |
P14679 | TYRO_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P09917 | LOX5_HUMAN | Asthma [ICD-11: CA23] |
P09917 | LOX5_HUMAN | Filariasis [ICD-11: 1F66] |
P09917 | LOX5_HUMAN | Thrombocytopenia [ICD-11: 3B64] |
P09917 | LOX5_HUMAN | Lung cancer [ICD-11: 2C25] |
P09917 | LOX5_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P09917 | LOX5_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P09917 | LOX5_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P09917 | LOX5_HUMAN | Atopic eczema [ICD-11: EA80] |
P09917 | LOX5_HUMAN | Carcinoid syndrome [ICD-11: 5B10] |
P09917 | LOX5_HUMAN | Fungal infection [ICD-11: 1F29-1F2F] |
P09917 | LOX5_HUMAN | Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P09917 | LOX5_HUMAN | Influenza [ICD-11: 1E30-1E32] |
P09917 | LOX5_HUMAN | Pituitary gland disorder [ICD-11: 5A60-5A61] |
P09917 | LOX5_HUMAN | Psoriasis [ICD-11: EA90] |
P09917 | LOX5_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09917 | LOX5_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P09917 | LOX5_HUMAN | Respiratory system disease [ICD-11: CB40-CB7Z] |
P09917 | LOX5_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P09917 | LOX5_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P09917 | LOX5_HUMAN | Eczema [ICD-11: EA80-EA89] |
P09917 | LOX5_HUMAN | Pruritus [ICD-11: EC90] |
P09917 | LOX5_HUMAN | Thrombosis [ICD-11: DB61-GB90] |
P09917 | LOX5_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
P09917 | LOX5_HUMAN | Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P09917 | LOX5_HUMAN | Arterial occlusive disease [ICD-11: BD40] |
P09917 | LOX5_HUMAN | Malaria [ICD-11: 1F40-1F45] |
P09917 | LOX5_HUMAN | Asthma [ICD-11: CA23] |
P09917 | LOX5_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P09917 | LOX5_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P56524 | HDAC4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P56524 | HDAC4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q00987 | MDM2_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
Q00987 | MDM2_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q00987 | MDM2_HUMAN | Myeloproliferative neoplasm [ICD-11: 2A20] |
Q00987 | MDM2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q00987 | MDM2_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
Q00987 | MDM2_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
Q00987 | MDM2_HUMAN | Neuroendocrine carcinoma [ICD-11: 2C34] |
Q00987 | MDM2_HUMAN | Liposarcoma [ICD-11: 2B59] |
Q00987 | MDM2_HUMAN | Lung cancer [ICD-11: 2C25] |
Q00987 | MDM2_HUMAN | Prostate cancer [ICD-11: 2C82] |
Q00987 | MDM2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q00987 | MDM2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92769 | HDAC2_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
Q92769 | HDAC2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92769 | HDAC2_HUMAN | Eczema [ICD-11: EA80-EA89] |
Q9BY41 | HDAC8_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q9BY41 | HDAC8_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O15151 | MDM4_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O15151 | MDM4_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O15151 | MDM4_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
O15151 | MDM4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |